Admetsys has developed a first-of-its-kind artificial pancreas for hospital and surgical care, leveraging
adaptive learning algorithms and counterbalancing treatment of insulin and glucose.
between 80-125 mg/dL
< 70 mg/dL
2.5 hrs Mean Time
Frequent measures are critical for a clear glycemic picture.
In one retrospective study, average
frequency was 2.6 hours despite
a goal of hourly checks.
A 12-minute measurement delay (from hourly)
was associated with 67% of severe
86% of nurses in one study felt that an easier or more automated
form of measurement was needed.
Proper diabetic control:
& Regulatory Risk
Standard of Care
Want to get involved and be a part of Admetsys?
Join us as an Advocate, Advisor or Investor.
We'll never send you spam.
We hate spam.
For people at diabetic risk, glucose control is at its most
crucial while in hospital or surgery. Correcting abnormal
glucose levels and keeping them normal speeds recovery,
prevents infection, and reduces complications. To date,
this has been difficult, highly labor-intensive, and imprecise.
That is about to change.
Admetsys has conducted 3 clinical trials with outstanding results:
Watch the video to Learn More
Source: American Diabetes Association (ADA).
The market is in the need of better solution.
$245 Billion – 2012 Estimated Cost of Diabetes in USA
41% Increase over 5 years
(2007 to 2012)
43% of the total medical cost
– hospital inpatient care